Summary by Futu AI
Four Ring Pharmaceutical Holdings Group Co., Ltd. (“Four Ring Pharmaceuticals”) will hold its Annual General Meeting on June 7, 2024 at the Hilton Shenzhen Grand China in Futian District, Shenzhen, China. The meeting will discuss and vote on matters including general mandates to issue and repurchase shares, re-election of retiring directors, etc. Quadruple Pharmaceuticals proposes to grant the directors a general mandate to issue shares, to issue up to 20% of the total issued shares and to repurchase shares not exceeding 10% of the total issued shares. The Notice of the Annual General Meeting and the related proxy form have been published on the Company's website and on the website of the United Stock Exchange Limited. Fourcircle Pharmaceuticals will also suspend the...Show More